P
Philippe Gabriel Steg
Researcher at National Institutes of Health
Publications - 98
Citations - 5804
Philippe Gabriel Steg is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Myocardial infarction & Percutaneous coronary intervention. The author has an hindex of 24, co-authored 98 publications receiving 4480 citations. Previous affiliations of Philippe Gabriel Steg include Imperial College London & University of North Carolina at Chapel Hill.
Papers
More filters
Journal ArticleDOI
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
Marc P. Bonaca,Deepak L. Bhatt,Marc Cohen,Philippe Gabriel Steg,Robert F. Storey,Eva C. Jensen,Giulia Magnani,Sameer Bansilal,M. Polly Fish,KyungAh Im,Olof Bengtsson,Ton Oude Ophuis,Andrzej Budaj,Pierre Theroux,Mikhail Ruda,Christian W. Hamm,Shinya Goto,Jindrich Spinar,Jose C. Nicolau,Róbert Gábor Kiss,Sabina A. Murphy,Stephen D. Wiviott,Peter Held,Eugene Braunwald,Marc S. Sabatine +24 more
TL;DR: In patients with a myocardial infarction more than 1 year previously, treatment with ticagrelor significantly reduced the risk of cardiovascular death, my Cardiac Infarction, or stroke and increased therisk of major bleeding.
Journal ArticleDOI
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials
Francesco Costa,Francesco Costa,Francesco Costa,David van Klaveren,David van Klaveren,Stefan James,Dik Heg,Lorenz Räber,Fausto Feres,Thomas Pilgrim,Myeong Ki Hong,Hyo-Soo Kim,Antonio Colombo,Philippe Gabriel Steg,Thomas Zanchin,Tullio Palmerini,Lars Wallentin,Deepak L. Bhatt,Gregg W. Stone,Stephan Windecker,Ewout W. Steyerberg,Marco Valgimigli,Marco Valgimigli +22 more
TL;DR: The PRECISE-DAPT score is a simple five-item risk score, which provides a standardised tool for the prediction of out-of-hospital bleeding during DAPT and can support clinical decision making for treatment duration.
Journal ArticleDOI
Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.
Robert W. Yeh,Robert W. Yeh,Eric A. Secemsky,Dean J. Kereiakes,Sharon-Lise T. Normand,Anthony H. Gershlick,Anthony H. Gershlick,David J. Cohen,John A. Spertus,John A. Spertus,Philippe Gabriel Steg,Philippe Gabriel Steg,Donald E. Cutlip,Donald E. Cutlip,Michael J. Rinaldi,Edoardo Camenzind,William Wijns,Patricia Apruzzese,Yang Song,Joseph M. Massaro,Joseph M. Massaro,Laura Mauri,Laura Mauri +22 more
TL;DR: A clinical decision tool to identify patients expected to derive benefit vs harm from continuing thienopyridine beyond 1 year after percutaneous coronary intervention is developed to inform dual antiplatelet therapy duration.
Journal ArticleDOI
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
Pascal Vranckx,Marco Valgimigli,Peter Jüni,Christian W. Hamm,Philippe Gabriel Steg,Philippe Gabriel Steg,Dik Heg,Gerrit Anne van Es,Eùgene P. McFadden,Yoshinobu Onuma,Cokky van Meijeren,Ply Chichareon,Edouard Benit,Helge Möllmann,Luc Janssens,Maurizio Ferrario,Aris Moschovitis,Aleksander Zurakowski,Marcello Dominici,Robert-Jan van Geuns,Kurt Huber,Ton Slagboom,Patrick W. Serruys,Patrick W. Serruys,Stephan Windecker,Mohamed Abdellaoui,David Adlam,Ibrahim Akin,Agustin Albarran Gonzalez-Trevilla,Manuel de Sousa Almeida,Pedro Alves Lemos Neto,Adel Aminian,Richard A. Anderson,Rick Andreae,Michael Angioi,Taku Asano,Emanuele Barbato,Peter Barlis,Pascal Barraud,Olivier F. Bertrand,Farzin Beygui,Leonardo Bolognese,Roberto Botelho,Coby Bouwman,Marco Bressers,Philippe Brunel,Paweł Buszman,Ian Buysschaert,Pedro Canas da Silva,Didier Carrié,Angel Cequier,Chun Chin Chang,Saqib Chowdhary,Carlos Collet,Antonio Colombo,James Cotton,Rui Cruz Ferreira,Salvatore Curello,Nick Curzen,Judith de Bot,Tone de Vreede,Georg Delle Karth,Lynn Dijksma,István Édes,Eric Eeckhout,Ingo Eitel,József Faluközy,Farzin Fath-Ordoubadi,Géza Fontos,Jose Francisco Diaz,Edgard Freitas Quintella,Bernhard Frey,Guy Friedrich,Gavin Galasko,Grzegorz Galuszka,Vasco Gama Ribeiro,Scot Garg,Giuseppe Gargiulo,Tobias Geisler,Valeri Gelev,Art Ghandilyan,Javier Goicolea,Tommaso Gori,Felice Gragnano,Ana H.C. Guimarães,Michael Haude,Pieter Heijke,Rosa Ana Hernández Antolin,David Hildick-Smith,Dorien Hillen,Ina Hoekman,Sjoerd H. Hofma,Lene Holmvang,Stephen P. Hoole,Iván Horváth,Annemarie Hugense,Karim Ibrahim,Andrés Iñiguez,Karl Isaaz,Zoltan Jambrik,Pawel Jasionowicz,Judith Jonk,Werner Jung,Yuki Katagiri,Norihiro Kogame,Tian Hai Koh,René Koning,Mariana Konteva,Zsolt Kőszegi,Florian Krackhardt,Yvonne Kreuger,Neville Kukreja,Boudijn Ladan,Pierre Lantelme,Sergio Leandro,Gregor Leibundgut,Christoph Liebetrau,Wietze Lindeboom,Carlos Macaya Miguel,François Mach,Michael Magro,Luc Maillard,Negar Manavifar,Laura Mauri,Eugene P. McFadden,Béla Merkely,Yosuke Miyazaki,Adam Młodziankowski,Tiziano Moccetti,Rodrigo Modolo,Helge Möllman,Jean-François Morelle,Michael Munndt Ottesen,Martin Muurling,Christoph Naber,Franz-Josef Neumann,Keith G. Oldroyd,Paul J.L. Ong,Sanne Palsrok,Ivo Petrov,Sylvain Plante,Janusz Prokopczuk,Tessa Rademaker-Havinga,Christopher Raffel,Benno J. Rensing,Marco Roffi,Kees-Jan Royaards,Manel Sabaté,Volker Schächinger,Tim Seidler,Antonio Serra Peñaranda,Patrick W. Serruys,Lali Sikarulidze,Osama Ibrahim Ibrahim Soliman,Amanda Sousa,Ernest Spitzer,Rod Stables,Gabriel Steg,Clemens Steinwender,Eduardas Subkovas,Harry Suryapranata,Kuniaki Takahashi,Suneel Talwar,Emmanuel Teiger,Addy ter Weele,Eva Teurlings,Attila Thury,Jan Tijssen,Gincho Tonev,Diana Trendafilova-Lazarova,Carlo Tumscitz,Victor A. Umans,Imre Ungi,Veselin Valkov,Pim van der Harst,Dobrin Vassilev,Vasil Velchev,Esther Velthuizen,Freek W.A. Verheugt,Natalia Vlcek,Jürgen vom Dahl,Mathias Vrolix,Simon J Walsh,Nikos Werner,Maarten Witsenburg,Azfar Zaman,Krzysztof Żmudka,Bernhard Zrenner,Robert Zweiker +188 more
TL;DR: The GLOBAL LEADERS trial as discussed by the authors showed that ticagrelor, in combination with aspirin for 1 month, followed by ticaragrelor alone, improves outcomes after percutaneous coronary intervention compared with standard antiplatelet regimens.
Journal ArticleDOI
Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis.
Sammy Elmariah,Laura Mauri,Laura Mauri,Gheorghe Doros,Gheorghe Doros,Benjamin Z. Galper,Kelly E O'Neill,Philippe Gabriel Steg,Philippe Gabriel Steg,Philippe Gabriel Steg,Dean J. Kereiakes,Robert W. Yeh +11 more
TL;DR: Extended duration dual antiplatelet therapy was not associated with a difference in the risk of all-cause, cardiovascular, or non-cardiovascular death compared with aspirin alone or short durationDual antiplatelets therapy.